NCT07398430Not yet recruiting
Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea
Metabolic Characteristics Analysis and Precise Prognostic Model Establishment for Patients With Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea
Source: ClinicalTrials.gov · Last updated 9 Feb 2026
Brief summary (registry, in English)
Obstructive sleep apnea (OSA) significantly increases the risk of cardiovascular events in patients with acute coronary syndrome (ACS), yet the underlying metabolic mechanisms remain unclear. This study aims to analyze the metabolic characteristics of ACS patients with OSA using metabolomics based on a prospective cohort. The study intends to construct an artificial intelligence-based risk stratification model to improve prognosis prediction and facilitate precision medicine for this population.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 4 Feb 2026
- Start date
- 1 Feb 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Beijing Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT07398430
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 1 Feb 2026 to the primary completion date, 31 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous or current treatment with continuous positive airway pressure.
Other illness
- Cardiogenic shock or cardiac arrest.
- Malignancy or life expectancy \< 1 year.
Other
- Central sleep apnea or other types of sleep disordered breathing.
- Inability to complete polysomnography or invalid data.
Who the study is looking for
- Age 18-85 years.
- Diagnosed with ACS, including ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina.
- Willing to participate and sign the informed consent form.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.